Furthermore, the present findings confirmed that CCL4 has profound impacts on tumor microenvironment remodeling, accounting for the status switch from metabolism to immunity and tumor proliferation, which may cast new lights on the crucial status of immune-related molecules involved in immunomodulation and tumor progression. The gene discussed is CCL4; the disease is neoplasm.